Monitor whether Trian engages in further negotiations, launches a tender offer at a higher price, or challenges the rights plan in court. The one-year duration of the pill and the absence of dead-hand provisions leave the door open for a negotiated deal if the board deems it fair.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $7.94entry
- T+1 · 11d ago +2.64%α +2.33% · $8.15
- T+5 · 5d ago +3.02%α −0.27% · $8.18
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Wendy's adopted a limited-duration shareholder rights plan (poison pill) with a 15% trigger, expiring November 3, 2027, in response to Trian's unsolicited $7.35/share takeover proposal. The independent committee rejected the proposal as undervaluing the company. The board also amended equity plans to remove the Trian/Peltz exclusion from the change-in-control definition and extended post-change-in-control severance protection to 18 months.
Key Facts
- Board adopted a shareholder rights plan with a 15% beneficial ownership trigger, expiring November 3, 2027
- Rights plan was adopted in response to Trian-led group's unsolicited $7.35/share cash proposal to acquire shares not already owned by the group
- Independent committee unanimously rejected the $7.35/share proposal as substantially undervaluing the company
- Trian is grandfathered as a 15%+ holder but cannot acquire additional shares without triggering the pill
- Board amended the 2020 Omnibus Award Plan to remove the exclusion for transactions involving Nelson Peltz/Peter W. May from the change-in-control definition
- Post-change-in-control severance protection period extended from 12 to 18 months under the Executive Severance Pay Policy
- Rights plan has no dead-hand, slow-hand, or no-hand features
- Morgan Stanley, Goldman Sachs, and Simpson Thacher are advising the independent committee
Financial Impact
No financial figures disclosed; rights plan has $0.001 per right redemption price; Trian's proposal was $7.35/share cash for shares not already owned
Risk Factors
- Trian may launch a proxy contest or litigation to challenge the rights plan
- The rights plan could deter other potential acquirers from making a bid
- Trian's grandfathered status means it can maintain its current stake without triggering the pill, but any additional purchases would trigger severe dilution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-448576 |
| Document: d305992d8k.htm | 0001193125-26-448576 |
| Document: d305992dex107.htm | 0001193125-26-448576 |
| Document: d305992dex106.htm | 0001193125-26-448576 |
| Document: d305992dex105.htm | 0001193125-26-448576 |
| Document: d305992dex104.htm | 0001193125-26-448576 |
| Document: d305992dex31.htm | 0001193125-26-448576 |
| Document: d305992dex991.htm | 0001193125-26-448576 |
| Document: d305992dex103.htm | 0001193125-26-448576 |
| Document: d305992dex102.htm | 0001193125-26-448576 |
Track record
11 reports on WEN
2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +8.20% at T+5 after the Oct 28, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 5/10 Viewing Entry $7.94 to $8.15 Now $8.47 +6.68% ▲ +2.64% +2.33% vs SPY
- Nov 5, 202611d ago 8-K Bearish 6/10 Entry $7.94 to $8.15 Now $8.47 −6.68% ▼ −2.64% −2.33% vs SPY
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $7.65 to $7.94 Now $8.47 +10.72% ▲ +3.79% +8.20% vs SPY
- Oct 28, 202619d ago SC 13D/A Bullish 6/10 Entry $7.07 to $7.17 Now $8.47 +19.80% ▲ +1.34% +1.73% vs SPY
- Aug 17, 202613w ago 8-K Neutral 3/10 Entry $8.44 to $8.93 Now $8.47 +0.36% ▲ +5.81% +5.60% vs SPY
- Aug 7, 202614w ago 8-K Bearish 8/10 Entry $7.69 to $7.28 Now $8.47 −10.17% ▲ +5.33% +5.30% vs SPY
- Jul 9, 202618w ago Press Release Neutral 1/10 Entry $7.55 Now $8.47 +12.19% No price data
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $6.79 to $6.79 Now $8.47 −24.74% · 0.00% +0.54% vs SPY
- Jun 9, 202622w ago 8-K Neutral 2/10 Entry $6.63 to $6.79 Now $8.47 +27.75% ▲ +2.41% +0.71% vs SPY
- May 22, 202625w ago 8-K Neutral 3/10 Entry $7.36 to $7.48 Now $8.47 +15.11% ▲ +1.64% +1.63% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers